#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dilated cardiomyopathy Fallopian tube cancer Gaucher's disease type I Kearns-Sayre syndrome Activated PI3 kinase delta syndrome Still's disease Adenocarcinoma pancreas Dementia Alzheimer's type Primary adrenal insufficiency Desmoplastic small round cell tumour Ewing's sarcoma metastatic Marginal zone lymphoma Bile acid synthesis disorder Immunodeficiency Glycogen storage disease type V More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Basic Information Ewing’s sarcoma metastatic – Treatment Alternating hemiplegia of childhood – Basic Information Familial amyotrophic lateral sclerosis – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Hereditary angioedema Mucopolysaccharidosis III – Life with Disease Myelodysplastic syndrome – Life with Disease Myxofibrosarcoma – Diagnostics Cystic fibrosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pf-07220060 Monohydrate Masupirdine Ecoo18A Fluticasone Propionate Venetoclax Palbociclib Camphor Lazertinib Cldn6 Car-T(A) Corline Heparin Conjugate Omaveloxolone Haloperidol Decanoate Tabelecleucel Gentamicin Tadalafil IHMA-2121771-1 ZIRCONIUM (89ZR) GIRENTUXIMAB TETRODOTOXIN Vidofludimus Calcium Entinostat More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis Intestinal ischaemia Magnetic resonance imaging Primary hypercholesterolaemia Oral neoplasm Chronic spontaneous urticaria Hand dermatitis Obliterative bronchiolitis Psoriasis Liposarcoma recurrent Lennox-Gastaut syndrome Athetosis Non-small cell lung cancer Neuralgia Respiratory distress More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiovascular Diseases

  • Bempedoic acid in drug combination for patients with coronary artery disease without prior cardiovascular events

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    Investigated Drugs:
    • Bempedoic Acid
    • Ezetimibe
    • Rosuvastatin
    Germany Italy Spain

  • Bisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    • Acute myocardial infarction
    Investigated Drugs:
    • Bisoprolol
    Belgium

  • Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

    Recruiting

    4 1 1
    Investigated Drugs:
    • ALLOGENEIC VEIN TISSUE SEGMENT, DECELLULARISED, WITH A FUNCTIONAL VALVE PERFUSED WITH AUTOLOGOUS PERIPHERAL BLOOD
    Spain

  • A study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    Denmark

  • Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Ezetimibe
    Spain

  • A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation

    Recruiting

    4 1 1
    Poland
1 2 3 … 123
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!